Kissei Pharmaceutical Co., Ltd. (4547.T)
JPY 3635.0
(0.0%)
JPY 3635.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 39.79 Billion JPY | 50.8% |
| 2022 | 26.38 Billion JPY | -26.52% |
| 2021 | 35.9 Billion JPY | -26.58% |
| 2020 | 48.9 Billion JPY | 25.97% |
| 2019 | 38.82 Billion JPY | 25.99% |
| 2018 | 30.81 Billion JPY | -16.7% |
| 2017 | 36.99 Billion JPY | 27.49% |
| 2016 | 29.01 Billion JPY | -17.61% |
| 2015 | 35.22 Billion JPY | 14.48% |
| 2014 | 30.76 Billion JPY | 3.14% |
| 2013 | 29.82 Billion JPY | 18.16% |
| 2012 | 25.24 Billion JPY | 20.21% |
| 2011 | 21 Billion JPY | -5.9% |
| 2010 | 22.31 Billion JPY | -2.13% |
| 2009 | 22.8 Billion JPY | 4.76% |
| 2008 | 21.76 Billion JPY | -31.53% |
| 2007 | 31.79 Billion JPY | -21.21% |
| 2006 | 40.34 Billion JPY | -18.92% |
| 2005 | 49.76 Billion JPY | 11.16% |
| 2004 | 44.76 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | - JPY | 147.54% |
| 2024 Q1 | 15.98 Billion JPY | -59.83% |
| 2023 Q4 | 39.79 Billion JPY | 28.93% |
| 2023 FY | 39.79 Billion JPY | 50.8% |
| 2023 Q3 | 30.86 Billion JPY | 2.02% |
| 2023 Q1 | 28.34 Billion JPY | 7.42% |
| 2023 Q2 | 30.25 Billion JPY | 6.73% |
| 2022 Q3 | 33.69 Billion JPY | 3.13% |
| 2022 Q4 | 26.38 Billion JPY | -21.7% |
| 2022 FY | 26.38 Billion JPY | -26.52% |
| 2022 Q1 | 32.56 Billion JPY | -9.3% |
| 2022 Q2 | 32.67 Billion JPY | 0.33% |
| 2021 FY | 35.9 Billion JPY | -26.58% |
| 2021 Q2 | 43.85 Billion JPY | -3.28% |
| 2021 Q4 | 35.9 Billion JPY | -7.69% |
| 2021 Q1 | 45.34 Billion JPY | -7.29% |
| 2021 Q3 | 38.9 Billion JPY | -11.3% |
| 2020 Q1 | 46.14 Billion JPY | 18.85% |
| 2020 Q4 | 48.9 Billion JPY | 2.25% |
| 2020 FY | 48.9 Billion JPY | 25.97% |
| 2020 Q2 | 47.44 Billion JPY | 2.82% |
| 2020 Q3 | 47.83 Billion JPY | 0.81% |
| 2019 Q1 | 29.58 Billion JPY | -4.0% |
| 2019 Q3 | 34.88 Billion JPY | 3.85% |
| 2019 Q4 | 38.82 Billion JPY | 11.3% |
| 2019 Q2 | 33.58 Billion JPY | 13.55% |
| 2019 FY | 38.82 Billion JPY | 25.99% |
| 2018 FY | 30.81 Billion JPY | -16.7% |
| 2018 Q4 | 30.81 Billion JPY | 8.38% |
| 2018 Q3 | 28.43 Billion JPY | -21.76% |
| 2018 Q1 | 32.11 Billion JPY | -13.19% |
| 2018 Q2 | 36.34 Billion JPY | 13.15% |
| 2017 Q3 | 35.01 Billion JPY | 9.69% |
| 2017 Q1 | 29.66 Billion JPY | 2.22% |
| 2017 Q4 | 36.99 Billion JPY | 5.67% |
| 2017 FY | 36.99 Billion JPY | 27.49% |
| 2017 Q2 | 31.91 Billion JPY | 7.61% |
| 2016 Q2 | 30.42 Billion JPY | 0.66% |
| 2016 Q3 | 28.8 Billion JPY | -5.33% |
| 2016 FY | 29.01 Billion JPY | -17.61% |
| 2016 Q1 | 30.22 Billion JPY | -14.19% |
| 2016 Q4 | 29.01 Billion JPY | 0.75% |
| 2015 Q3 | 28.97 Billion JPY | 8.2% |
| 2015 Q2 | 26.77 Billion JPY | -7.07% |
| 2015 Q1 | 28.81 Billion JPY | -6.35% |
| 2015 FY | 35.22 Billion JPY | 14.48% |
| 2015 Q4 | 35.22 Billion JPY | 21.58% |
| 2014 Q2 | 29.07 Billion JPY | 10.45% |
| 2014 Q3 | 27.31 Billion JPY | -6.08% |
| 2014 FY | 30.76 Billion JPY | 3.14% |
| 2014 Q4 | 30.76 Billion JPY | 12.65% |
| 2014 Q1 | 26.32 Billion JPY | -11.74% |
| 2013 Q1 | 24.75 Billion JPY | -1.94% |
| 2013 Q3 | 27.51 Billion JPY | 9.21% |
| 2013 Q4 | 29.82 Billion JPY | 8.43% |
| 2013 FY | 29.82 Billion JPY | 18.16% |
| 2013 Q2 | 25.19 Billion JPY | 1.76% |
| 2012 Q3 | 20.42 Billion JPY | -2.89% |
| 2012 Q2 | 21.03 Billion JPY | -0.46% |
| 2012 FY | 25.24 Billion JPY | 20.21% |
| 2012 Q1 | 21.13 Billion JPY | 0.62% |
| 2012 Q4 | 25.24 Billion JPY | 23.59% |
| 2011 FY | 21 Billion JPY | -5.9% |
| 2011 Q4 | 21 Billion JPY | 0.79% |
| 2011 Q2 | 22.35 Billion JPY | -0.71% |
| 2011 Q1 | 22.51 Billion JPY | 0.89% |
| 2011 Q3 | 20.83 Billion JPY | -6.8% |
| 2010 Q3 | 19.88 Billion JPY | -1.98% |
| 2010 FY | 22.31 Billion JPY | -2.13% |
| 2010 Q4 | 22.31 Billion JPY | 12.25% |
| 2010 Q2 | 20.28 Billion JPY | -9.53% |
| 2010 Q1 | 22.41 Billion JPY | -1.68% |
| 2009 Q3 | 21.62 Billion JPY | -1.62% |
| 2009 Q2 | 21.98 Billion JPY | 0.0% |
| 2009 FY | 22.8 Billion JPY | 4.76% |
| 2009 Q4 | 22.8 Billion JPY | 5.43% |
| 2008 Q3 | 22.88 Billion JPY | 0.0% |
| 2008 FY | 21.76 Billion JPY | -31.53% |
| 2008 Q4 | 21.76 Billion JPY | -4.87% |
| 2007 FY | 31.79 Billion JPY | -21.21% |
| 2006 FY | 40.34 Billion JPY | -18.92% |
| 2005 FY | 49.76 Billion JPY | 11.16% |
| 2004 FY | 44.76 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -59.24% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.492% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 94.704% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | 75.789% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -1072.054% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | 7.178% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -42.794% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 91.959% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -689.504% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | 35.503% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -29.057% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | 0.008% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -28.011% |
| Tsumura & Co. | 132.88 Billion JPY | 70.056% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -199.248% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 85.518% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | 9.889% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 43.722% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | 15.145% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -468.199% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -56.417% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -388.705% |
| MedRx Co., Ltd | 129 Million JPY | -30745.736% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -1115.908% |
| Solasia Pharma K.K. | 673 Million JPY | -5812.481% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -6064.34% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -26.8% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 75.736% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -3834.483% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 92.406% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -472.34% |